abstract |
The present invention relates to a method for in vitro diagnosis of cancer colorectal by determining the presence of the Ezrin tumor marker in a biological sample from a patient suspected of having colorectal cancer using at least one anti-Ezrin monoclonal antibody directed against an epitope of Ezrin selected from SEQ ID sequence epitopes No. 1, SEQ ID No. 2, SEQ ID No. 3, SEQ ID No. 4 + SEQ ID No. 5, SEQ ID No. 6 + SEQ ID No. o7 and SEQ ID No. 8, said method being used both in early diagnosis, screening, therapeutic follow-up, prognosis, that in the diagnosis of relapses in the colorectal cancer setting. |